Phase 4 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 30 and 75 years old
- People with a body mass index (a measure of body weight relative to height) below 40
- People who are available and willing to take part in the study
- People who have a history of high blood pressure and are already receiving regular treatment for it, with blood pressure readings within a specific moderate range (systolic between 130–160 and diastolic between 80–100 mmHg) (confirm with trial site)
Who may not be able to join:
- People who currently use benzodiazepines (a type of sedative or anxiety medication) or so-called "Z drugs" (sleep medications such as zolpidem)
- People who work night shifts
- People with a history of severe chronic lung disease (COPD)
- People with heart failure where the heart is pumping at a significantly reduced capacity (confirmed by a heart scan)
- People who have previously had a stroke
- People with severe anxiety (based on a specific anxiety questionnaire score) or severe depression (based on a specific depression scale)
- People with severe liver disease
- People with alcohol misuse or dependency
- People with advanced kidney disease (stage 4 or 5, based on kidney filtering function)
- People currently taking a type of water tablet called loop diuretics
- People with type 1 diabetes
- People with poorly controlled type 2 diabetes (based on a blood sugar marker called glycated haemoglobin being above 10%)
- People with urinary incontinence (difficulty controlling bladder leakage)
- People with prostate-related urinary problems (prostatism)
- People with a current or active cancer diagnosis
- People who are pregnant
- People with complex sleep-related behaviours or a history of suicidal behaviour
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Luciano F. Drager, MD, PhD, University of Sao Paulo Medical School
Phone: +5511988027887
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of insomnia treatment on blood pressure (evaluated by Ambulatory blood pressure monitoring)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.